538634 Approves Q4 & FY26 Audited Financial Results

The Board of Directors of 538634, in a meeting held on May 28, 2026, approved and took on record the Audited Standalone Financial Results for the fourth quarter and financial year ended March 31, 2026. The company's statutory auditors issued an unmodified opinion on these financial results. Additionally, the Board appointed Mr. Ravi Jain as an Additional Non-executive Independent Director and noted the retirement of Mr. Pradeep Kumar Jain from the same position. Key committees, including the Audit, Nomination and Remuneration, and Stakeholders Relationship Committees, were reconstituted with Mr. Manish Jain as chairperson. The Board also approved a Memorandum of Understanding cum Loan-Lease Agreement with PandJ Cretechem Private Limited (the Holding Company) for Active Pharmaceutical Ingredients (APIs) manufacturing.